Figure_4.tif (555.29 kB)
Neutralization of DENV RVPs using WHO human reference sera.
figure
posted on 2011-11-09, 01:29 authored by Kimberly Mattia, Bridget A. Puffer, Katherine L. Williams, Ritela Gonzalez, Meredith Murray, Emily Sluzas, Dan Pagano, Sandya Ajith, Megan Bower, Eli Berdougo, Eva Harris, Benjamin J. DoranzDENV RVPs representing each of the four serotypes were pre-incubated for 1 hour with a WHO reference panel of human primary sera reactive to each RVP serotype (monovalent, squares: anti-DENV-1 serum in A; anti-DENV-2 in B; anti-DENV-3 in C; anti-DENV-4 in D) or reactive to all serotypes (tetravalent, triangles in all four panels). Naïve serum was used as a negative control. After incubation, DENV RVPs were used to infect Raji DC-SIGN-R cells. Forty-eight hours after infection, cells were quantified for GFP expression by flow cytometry (n = 3, error bars represent the standard deviation).